HSBC Holdings
GH icon

HSBC Holdings’s Guardant Health GH Stock Holding History

HSBC Holdings’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.13M Buy
98,843
+90,392
+1,070% +$9.08M ﹤0.01% 959
2025
Q4 		$863K Buy
8,451
+2,743
+48% +$245K ﹤0.01% 2023
2025
Q3 		$356K Sell
5,708
-46,334
-89% -$2.52M ﹤0.01% 2263
2025
Q2 		$2.69M Buy
52,042
+33,230
+177% +$1.48M ﹤0.01% 1370
2025
Q1 		$800K Sell
18,812
-199
-1% -$8.59K ﹤0.01% 1851
2024
Q4 		$582K Buy
19,011
+3,863
+26% +$109K ﹤0.01% 2084
2024
Q3 		$347K Sell
15,148
-54,598
-78% -$1.55M ﹤0.01% 2235
2024
Q2 		$2.01M Sell
69,746
-22,421
-24% -$522K ﹤0.01% 1402
2024
Q1 		$1.9M Buy
92,167
+48,635
+112% +$1.04M ﹤0.01% 1502
2023
Q4 		$1.18M Buy
43,532
+26,191
+151% +$687K ﹤0.01% 1699
2023
Q3 		$508K Sell
17,341
-23,309
-57% -$820K ﹤0.01% 1988
2023
Q2 		$1.46M Buy
40,650
+23,726
+140% +$681K ﹤0.01% 1566
2023
Q1 		$398K Buy
+16,924
New +$483K ﹤0.01% 2123
2022
Q4 		– Sell
-19,485
Closed -$1.05M – 3084
2022
Q3 		$1.05M Hold
19,485
– – ﹤0.01% 1809
2022
Q2 		$786K Sell
19,485
-931
-5% -$46.1K ﹤0.01% 2062
2022
Q1 		$1.35M Buy
20,416
+5,295
+35% +$362K ﹤0.01% 1775
2021
Q4 		$1.51M Buy
15,121
+2,628
+21% +$272K ﹤0.01% 1814
2021
Q3 		$1.57M Sell
12,493
-3,448
-22% -$410K ﹤0.01% 1638
2021
Q2 		$1.98M Buy
15,941
+8,931
+127% +$1.2M ﹤0.01% 1450
2021
Q1 		$1.08M Sell
7,010
-6,788
-49% -$1.03M ﹤0.01% 1553
2020
Q4 		$1.77M Buy
13,798
+11,506
+502% +$1.32M ﹤0.01% 1383
2020
Q3 		$257K Buy
+2,292
New +$210K ﹤0.01% 2339

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's GH Position: Q1 2026 in Review

HSBC Holdings increased its Guardant Health (GH) stake by 1,070% in Q1 2026, buying an estimated $9.08M and bringing the position to 98,843 shares worth $9.13M. The position accounts for ﹤0.01% of the portfolio, ranked #959.

HSBC Holdings first reported a position in GH in Q3 2020 and has held it in 22 quarters since. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • HSBC Holdings held 98,843 shares of Guardant Health worth $9.13M as of Q1 2026.
  • HSBC Holdings bought 90,392 Guardant Health shares in Q1 2026, an estimated $9.08M.
  • Guardant Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #959 holding.
  • HSBC Holdings first reported a position in Guardant Health in Q3 2020 and has held it in 22 quarters since.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.